Search

everythinglearnresearchcommunity

for

Search:↓

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Urologists prescribe newer medications more often than primary care physicians, who could benefit from more education on treatment options.

Urologists should screen for mental health issues before and during finasteride treatment.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Male pattern baldness may be linked to prostate cancer risk.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

Adopting the Mark Cuban Cost Plus Drug Company pricing model could save Medicare about $1.29 billion on urological drugs.

Prostate cancer prevention now focuses on healthy diets and some medications, not vitamins.

Generic urologic medication prices vary by pharmacy type, not by location or income level.

Pregnant female urologists should avoid certain drugs and use protective measures to stay safe.

Using more low-cost and generic drugs could save Medicare Part D a lot of money.

Trichothiodystrophy can be linked to urologic issues and high calcium in urine.

Long-term finasteride use may lower prostate cancer risk but increase the need for erectile dysfunction medication.

The conclusion is that future trials should report specific details about the PRP composition to better understand its effects on urologic conditions.

Independent pharmacies generally offer lower prices for certain generic urologic medications than chain pharmacies.

Post-void residual volume does not predict worsening urological symptoms in multiple sclerosis patients.

New, eco-friendly methods accurately measure TDF and FNS in a new urologic medication.

Adherence to finasteride treatment for prostate issues is generally low.

Men over 50 may experience hormone decline causing various symptoms, and proper management is crucial.

Patients should consult urologists for evidence-based erectile dysfunction treatments.

Young men's erectile dysfunction is linked to mental health issues and risky behaviors promoted by online communities, highlighting the need for better mental health support and healthy masculinity standards.

Botulinum toxin is used to treat many medical conditions beyond cosmetic purposes.

American men seeking infertility evaluation are generally older, more obese, have longer infertility duration, and different lifestyle habits compared to Canadian men.

Improving symptoms of male urinary problems may lower the risk of death.

Urologists should guide men on wellness claims, highlighting where evidence supports or contradicts marketing.

PRP shows promise in treating urological diseases but needs more research.